Genetic variation in UGT1A1typical of Gilbert syndrome is associated with unconjugated hyperbilirubinemia in patients receiving tocilizumab

MLA

Lee, Janet S., et al. “Genetic Variation in UGT1A1typical of Gilbert Syndrome Is Associated with Unconjugated Hyperbilirubinemia in Patients Receiving Tocilizumab.” Pharmacogenetics and Genomics, vol. 21, no. 7, July 2011, pp. 365–74. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edo&AN=ejs48719071&authtype=sso&custid=ns315887.

APA

Lee, J. S., Wang, J., Martin, M., Germer, S., Kenwright, A., Benayed, R., Spleiss, O., Platt, A., Pilson, R., Hemmings, A., Weinblatt, M. E., Kaplowitz, N., & Krasnow, J. (2011). Genetic variation in UGT1A1typical of Gilbert syndrome is associated with unconjugated hyperbilirubinemia in patients receiving tocilizumab. Pharmacogenetics and Genomics, 21(7), 365–374.

Chicago

Lee, Janet S., Jianmei Wang, Mitchell Martin, Soren Germer, Andrew Kenwright, Ryma Benayed, Olivia Spleiss, et al. 2011. “Genetic Variation in UGT1A1typical of Gilbert Syndrome Is Associated with Unconjugated Hyperbilirubinemia in Patients Receiving Tocilizumab.” Pharmacogenetics and Genomics 21 (7): 365–74. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edo&AN=ejs48719071&authtype=sso&custid=ns315887.